APGE (Apogee Therapeutics) Other Current Receivables: $7.28 Mil (As of Mar. 2026)


APGE Apogee Therapeutics Inc APGE
12 GF Score
Price $132.89
! 3 Warning Signs
View Full Analysis

What is Apogee Therapeutics Other Current Receivables?

Apogee Therapeutics APGE +0.11% 12 Other Current Receivables is $7.28 Mil as of Mar. 2026. GuruFocus rates APGE with a GF Score™ of 12/100. The stock has 3 warning signs investors should review.

Apogee Therapeutics's Other Current Receivables for the quarter that ended in Mar. 2026 was $7.28 Mil.

Apogee Therapeutics's quarterly Other Current Receivables increased from Sep. 2025 ($4.48 Mil) to Dec. 2025 ($5.96 Mil) and increased from Dec. 2025 ($5.96 Mil) to Mar. 2026 ($7.28 Mil).

Apogee Therapeutics's annual Other Current Receivables increased from Dec. 2023 ($1.21 Mil) to Dec. 2024 ($4.70 Mil) and increased from Dec. 2024 ($4.70 Mil) to Dec. 2025 ($5.96 Mil).

Apogee Therapeutics Other Current Receivables Related Terms

Apogee Therapeutics Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Apogee Therapeutics's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apogee Therapeutics Other Current Receivables Chart

Apogee Therapeutics Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Other Current Receivables
0.00 1.21 4.70 5.96

Apogee Therapeutics Quarterly Data
Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.01 4.14 4.48 5.96 7.28
APGE
12GF Score
Apogee Therapeutics Inc APGE
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apogee Therapeutics Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of $7.28 Mil mean?
Apogee Therapeutics (APGE) has a Other Current Receivables of $7.28 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Apogee Therapeutics and its competitors.
Is Apogee Therapeutics' Other Current Receivables too high?
Apogee Therapeutics' current Other Current Receivables is $7.28 Mil. Overall, Apogee Therapeutics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Apogee Therapeutics' Other Current Receivables compare to NUVL and CORT?
Apogee Therapeutics' Other Current Receivables of $7.28 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Apogee Therapeutics and its competitors. Apogee Therapeutics's current Other Current Receivables is $7.28 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apogee Therapeutics stock overvalued right now?
Apogee Therapeutics (APGE) has a current Other Current Receivables of $7.28 Mil. The current Other Current Receivables is $7.28 Mil. Apogee Therapeutics' overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Apogee Therapeutics (APGE), the current Other Current Receivables is $7.28 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Apogee Therapeutics Business Description

Address 221 Crescent Street, Building 17, Suite 102b, Waltham, MA, USA, 02453
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
12GF Score

Get the complete analysis for APGE

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$132.89
Price